NDC properties for NDC 9 73341-001
NDC item 73341000101
| NDC 9 | 73341-001 |
|---|
| NDC 10 | 73341-001-01 |
|---|
| NDC Item | 73341000101 |
|---|
| packaging | 454 g in 1 JAR (73341-001-01) |
|---|
| FDA SPL set id | 820161 |
|---|
| Labeler | M2B Pharma LLC |
|---|
| Label type | HUMAN OTC DRUG |
|---|
| Marketing category | OTC MONOGRAPH DRUG |
|---|
| Marketing effective time low | 2020-02-04 |
|---|
| Marketing status | ACTIVE |
|---|
| OTC_MONOGRAPH_DRUG | M017 |
|---|
NDC item 73341000130
| NDC 9 | 73341-001 |
|---|
| NDC 10 | 73341-001-30 |
|---|
| NDC Item | 73341000130 |
|---|
| packaging | 30 g in 1 JAR (73341-001-30) |
|---|
| FDA SPL set id | 820161 |
|---|
| Labeler | M2B Pharma LLC |
|---|
| Label type | HUMAN OTC DRUG |
|---|
| Marketing category | OTC MONOGRAPH DRUG |
|---|
| Marketing effective time low | 2020-02-04 |
|---|
| Marketing status | ACTIVE |
|---|
| OTC_MONOGRAPH_DRUG | M017 |
|---|